POLAR PHARMA INDIA LTD Q3 RESULTS
RVNL among India Inc's unlucky 13 with over 25% drop in both sales, profit in Q1
To maintain a premium valuation, a stock must demonstrate strong earnings growth and a positive future outlook. However, the June quarter results revealed that several prominent companies, including popular retail multibaggers, fell short in terms of earnings. ETMarkets reviewed companies with an m-cap of at least Rs 5,000 crore and identified 13 entities that reported at least a 25% YoY decline in sales and profit.
Ceigall India shares rally 7% after Q1 PAT jumps 80% YoY
Ceigall India Share Price: Ceigall India's shares rose by 7% on the BSE following the announcement of its first quarterly results, reporting an 80% YoY increase in net profit to Rs 80 crore. Revenue also saw a rise of 26.5% to Rs 822.40 crore. The company has won Rs 1,042 crores worth of new project orders in Kanpur and Bhuvaneshwar.
After 3 straight quarters of losses, these 10 companies cherish profits in Q1. Should you bet?
India's corporate earnings had a weak start in the first quarter of fiscal year 2025, with subdued revenues and negative profit growth. Despite this, ten companies, such as ASM Technologies and PC Jewellers, returned to profitability. Analysts recommend a careful, stock-specific approach due to elevated valuation risks in mid and small-cap sectors.
Bino Pathiparampil expects positive momentum in pharma sector; has 3 top picks
Bino Pathiparampil of Elara Capital discussed the strong Q1 FY25 performance in the pharma sector. Companies like Lupin and Dr Reddy's received upgrades, largely due to their success in the US market. Despite high valuations, the sector's positive momentum is likely to persist, with Zydus Lifesciences noted for future product launches.
Railway sector Q1 review: Average PAT decline 16% QoQ, revenue down 24%. What are your cues?
The railway sector reported an average 16% drop in net profits and a 24% revenue decline for the quarter ending June 30, 2024. Ten out of thirteen companies saw decreased profits, and all experienced revenue declines. Stocks have fallen by up to 32% from their 52-week highs, raising concerns about performance.
Glenmark Q1 Results: Net profit doubles to Rs 340 crore
Glenmark Pharma net profit doubled to Rs 340 crore crore in Q1FY25 led by robust sales growth in India and Europe and reduction in finance, depreciation and ammortisation costs.
- Go To Page 1
Vodafone Idea shares rally over 3% after narrowing Q1 losses. Should you invest?
Vodafone Idea's shares climbed 3.5% as it narrowed its Q1 2024 losses to Rs 6,432 crore. Revenue dipped slightly by 1.38% to Rs 10,508 crore. The company's ARPU grew to Rs 146 from Rs 139. Brokerages provided differing opinions on Vodafone Idea's future, amid concerns about debt and government support.
Hindalco Q1 Results: Cons PAT jumps 25% YoY to Rs 3,074 crore, revenue rises 8%
Hindalco Q1 Results: The Aditya Birla Group company's revenue from operations increased 7.6% to Rs 57,013 crore, and EBITDA surged 31% to Rs 7,992 crore. The India business achieved a 102% rise in consolidated PAT to Rs 1,957 crore.
Siemens India Q3 FY24 net profit jumps 27% YoY to Rs 578 crore
The company follows an October–September period to report its quarterly results. Total revenue was up 7% at Rs 5203 crore against Rs 4873 crore. The company’s new orders stood at Rs. 6,245 crore, an increase of 18% over the same period last year. Revenue from energy segment declined from Rs 1,518 crore to Rs 1,485 crore year-on-year.
Info Edge Q1 Results: Cons PAT jumps 47% YoY to Rs 233 crore, revenue rises 8%
The company's standalone net profit increased by 16% year-on-year to Rs 232 crore in the April-June quarter, compared to Rs 200 crore in the same period last year. Standalone revenue also grew by 9.3% to Rs 639 crore during the quarter, up from Rs 584 crore in the corresponding quarter of the previous fiscal year.
Berger Paints Q1 Results: Net profit falls marginally YoY to Rs 354 crore even as India volumes grow 12%
At a standalone level, the paint-maker’s sales rose 2.4% on year to Rs 2,806.3 crore, but net profit declined by more than 6% to Rs 305.5 crore. Berger Paints, which is among the largest paint-makers in the country, improved its market share to 20.9% during the quarter, up from 19.7% in the previous fiscal.
SAIL Q1 Results: Net profit slumps 93% YoY to Rs 11 crore on weak pricing, exceptional item
The steel maker had an exceptional loss of Rs 312 crore. The state-owned steel company reported a 3% year-on-year increase in steel sales during the quarter, reaching 4.01 million tonnes. Despite a slight 1.5% decrease in revenue to Rs 23,998 crore, the company's core operations remained strong with a 15% rise in earnings before interest, tax, depreciation and amortisation (EBITDA) to Rs 2,420 crore.
Page Industries Q1 Results: Net profit rises 4.3% YoY to Rs 165.22 crore
The revenue increased by 3.9% from Rs. 1,229.07 crores to Rs. 1,277.52 crores in the period under review. The sales volume grew by 2.6% year-on-year to 5.74 crore pieces
Alembic Pharma Q1 Results: Net profit rises 12% YoY to Rs 135 crore
Earnings before interest, tax, depreciation and amortisation (EBITDA) rose 14% YoY to Rs 239 crore, while the EBITDA margins contracted 540 basis points on y-o-y basis to 15.3%
AstraZeneca Q1 Results: Net loss reported at Rs 12 cr
Total income stood at Rs 396 crore for the June quarter against Rs 303 crore in the year-ago period, AstraZeneca Pharma India said in a regulatory filing
Lupin shares surge 6%, hit 52-week high post robust Q1 result
Lupin Share Price: Lupin's shares jumped 6% to a 52-week high after the company announced a 77.2% increase in net profit for the June quarter of FY25. The firm's net profit was Rs 801.3 crore, and revenue rose 16.3% to Rs 5,600.3 crore. Nomura maintained a 'Buy' rating, forecasting continued growth.
Q1 results today: Vedanta among 132 companies to announce earnings on Tuesday
During the first quarter earnings season, 132 companies, including PFC and Tata Power, were scheduled to announce their financial results. Vedanta's net profit was expected to range between Rs 2,197-3,060 crore, with revenue estimates between Rs 35,440-38,674 crore for June 2024. Different brokerages provided varying growth predictions.
SBI shares drop 3% post Q1 results. Should you buy, sell or hold?
SBI Share Price: State Bank of India's shares plunged 3% after it reported a standalone net profit of Rs 17,035 crore for the June quarter, marginally up from the previous year. Despite this, brokerages like Nomura, Jefferies, and Nuvama maintained their buy ratings, forecasting target prices between Rs 900 and Rs 1,030 amid stable asset quality and loan growth.
Bharti Airtel Q1 Preview: Revenue may grow by 3% YoY to Rs 38,488 crore, outlook positive
Bharti Airtel is expected to report a revenue of Rs 38,488 crore for Q1 FY24, marking a 2.6% YoY increase. Net profit estimates range from Rs 2,068 crore to Rs 3,922 crore. Axis Securities has the highest revenue estimate at Rs 38,996 crore, and Prabhudas Lilladher forecasts a decline in adjusted PAT.
BoI posts 10% YoY rise in Q1 net profit
Net Interest Income (NII), or the difference between the income earned on lending and cost of borrowing, increased 6% from a year ago to ₹6,275.8 crore, the bank said on Saturday.
SBI Q1 Results: PAT rises marginally YoY to Rs 17,035 crore, beats estimates
SBI Q1 Results: The public sector lender reported PAT at Rs 16,884.29 crore in the year-ago period. The Street had estimated PAT at around Rs 16,786 crore. During the reported quarter, the interest earned amounted to Rs 1,11,526 crore, marking a 16% increase compared to the Rs 95,975 crore reported by the lender in the same quarter of the previous financial year. The bank's interest expenditure for the April-June quarter was Rs 70,401 crore, up from Rs 57,041 crore, representing a 23% year-over-year increase.
Sun Pharma Q1 Results: Net profit rises 40% YoY to Rs 2,836 crore, beats estimates
Sun Pharma Q1 Results: Sun Pharma reported a 40% increase in consolidated net profit to Rs 2,836 crore, surpassing estimates of Rs 2,638 crore. Revenue rose 6% YoY to Rs 12,653 crore. EBITDA grew 8% YoY to Rs 3,608 crore with margins at 28.5%. India formulation sales reached Rs 4,144 crore, up 16%, constituting 33.1% of total sales.
Be a bit cautious in auto stocks and do not chase the particular rally in Maruti: Dipan Mehta
Dipan Mehta of Elixir Equities discussed the outlook for the auto and cement industries, noting potential slowdowns and increased competition. He commented on recent developments in speculative trading regulations, the pharma sector, and the performance of companies like Zomato, Paytm, and Maruti. Mehta advised caution in the auto sector while expressing optimism about select pharma stocks.
Mankind Pharma Q1 Results: Net profit jumps 10% to Rs 543 crore
The drug maker reported net profit of Rs 494 crore in the corresponding period of previous year.Revenue from operations rose 12.2% YoY to Rs 2,893 crore in Q1FY25. On a quarter-on-quarter (QoQ) basis revenue and net profit increased 18.5% and 14%, respectively.
Coal India Q1 Results: Profit rises 4% YoY to Rs 10,959 cr, beats estimates
Coal India Q1 Results: Revenue from operations during the April-June 2024 period was up marginally year-on-year to Rs 36,465 crore. Sequentially, net profit increased by 26% from Rs 8,682 crore reported in the previous March quarter. Meanwhile, revenue declined by 3% quarter-on-quarter. The company reported consolidated EBITDA of Rs 14,339 crore for the reporting quarter, with margins at 39.3%.
Maruti Suzuki Q1 Results: Profit soars 47% YoY to Rs 3,650 crore, beats estimates
Maruti Suzuki Q1 Results: India's largest carmaker, Maruti Suzuki, saw a 46.9% YoY rise in standalone profit to Rs 3,650 crore for Q1, exceeding the Street estimate of Rs 3,467 crore. However, revenue grew 9.82% YoY to Rs 33,875 crore, missing the Rs 34,770 crore estimate. Margins were 12.6%, above the 12% forecast, driving shares up over 4% to a record Rs 13,390 on the BSE.
Mankind Pharma Q1 Results: Profit rises 10% YoY to Rs 543 crore
Mankind Pharma Q1 Results: Revenue from operations for the same period increased by 12% year-on-year (YoY) to Rs 2,893 crore, up from Rs 2,579 crore in the previous year. The company reported an EBITDA of Rs 681 crore, reflecting a 4% YoY increase. However, margins for the quarter declined by 188 basis points to 23.54%.
Q1 results today: Maruti, M&M among 115 companies to announce earnings on Wednesday
Q1 results today: In the first quarter earnings season, 115 companies announced results, including Maruti, M&M, Coal India, Adani Power, Tata Steel, Ambuja, and Bank of Baroda. M&M and Maruti expected mixed revenue and profit changes, while Tata Steel's profit was predicted to rise notably amid a revenue drop. Several others also reported their quarterly performance.
Dr. Reddy's Lab Q1 Results: Profit down 1% to Rs 1,392 crore but revenue jumps 14%
Dr. Reddy's Lab Q1 Results: While announcing the quarterly numbers, the company's board also approved split of equity shares in the ratio of 1:5, which means that 1 existing share will split into 5. The company said its revenue growth during the quarter was largely driven by growth in global generics revenues in North America as well as India.
Load More
